Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 945-047-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not applicable
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Comparable to a guideline study and followed GLP.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Diethylenetriamine (DETA)
- IUPAC Name:
- Diethylenetriamine (DETA)
- Reference substance name:
- 2,2'-iminodi(ethylamine)
- EC Number:
- 203-865-4
- EC Name:
- 2,2'-iminodi(ethylamine)
- Cas Number:
- 111-40-0
- Molecular formula:
- C4H13N3
- IUPAC Name:
- N-(2-aminoethyl)ethane-1,2-diamine
- Test material form:
- other: Clear yellow liquid
- Details on test material:
- - Name of test material (as cited in study report): Diethylenetriamine (DETA)
- Physical state: Clear yellow liquid
- Analytical purity: 98.9%
- Lot/batch No.: F286E6QL79
- Expiration date of the lot/batch: 31 July 2016
- Storage condition of test material: Room temperature, protected from light, with nitrogen
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Wilmington, MA,
- Age at study initiation: Approximately 8-10 week old
- Weight at study initiation:
- Assigned to test groups randomly: yes
- Fasting period before study:
- Housing:housed singly in suspended wire-bottom cages
- Diet: Purina Certified Rodent Chow #5002 (Ralston Purina Company, Richmond, IN)
- Water: ad libitum
- Acclimation period:acclimatize for at least one week
ENVIRONMENTAL CONDITIONS
- Temperature (°F): 72 +/-5
- Humidity (%): 40-60
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water (negative control)
- Details on exposure:
- The test material and CP were dissolved in distilled water. Freshly prepared solutions (less than 2 hours old) were used for dosing the animals.
All doses of the test material and CP were administered by single oral gavage in aliquots of 10 ml/kg b.w. Negative control mice received 10 ml/kg b.w. distilled water. The animals were weighed the day prior to dosing and the dosing volumes were based upon individual body weights. - Duration of treatment / exposure:
- Exposure period: 24, 48, and 72 hours
- Frequency of treatment:
- Once
- Post exposure period:
- Not applicable
Doses / concentrations
- Remarks:
- Doses / Concentrations:
85, 283 and 850 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- Five
- Control animals:
- other: positive control chemical or water (negative control)
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): This dose level was based upon the experience of this laboratory and was selected to induce an unequivocal positive response.
- Route of administration: oral gavage
- Doses / concentrations:120 mg/kg b.w.
Examinations
- Tissues and cell types examined:
- Bone marrow
micronucleated polychromatic erythrocytes - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The highest dose for the micronucleus test was selected to be approximately 60% of the LD50 while the middle and low doses were one-third and one-tenth of the highest dose, respectively.
TREATMENT AND SAMPLING TIMES: At the end of the specified intervals following dosing, the animals were weighed and sacrificed by cervical dislocation . Bone marrow samples were obtained from both femurs in the following way.
DETAILS OF SLIDE PREPARATION: Bone marrow sampling: Cell smears were prepared on microscope slides using small portions
o f the cell suspension. The slides were allowed to air dry, fixed in methanol and stained in 5% Giemsa (Gollapudi and Kamra, 1979;
Heddl e and Sal amone, 1981) .
Slide scoring: The slides were coded and scored blindly. One thousand polychromatic erythrocytes were examined from each animal and the number o f micronucleated polychromatic erythrocytes (MN-PCE) was recorded. Micronuclei were i d e n t i f i e d as darkly stained bodies with sharp contours and varying shapes such as round, almond, or ring (Schmid, 1976).
METHOD OF ANALYSIS: The r a t i o o f PCE-NCE i n the bone marrow was determined by examining 200 erythrocytes. The r a t i o was expressed
as PCExlOO/PCE+NCE.
OTHER: - Evaluation criteria:
- Bone marrow erythrocytes are especially suitable for scoring micronuclei because of the following reasons. The erythroblasts, the precursors of
erythrocytes, expel their main nuclei shortly (5 h) after their last division.. However, if an erythroblast contains a micronucleus, it will not be expelled along with the main nucleus; and hence micronuclei can be scored in a cell population devoid of the main nucleus. Young erythrocytes stain differently from older forms due to the presence of ribosomal RNA. The process of maturation of the young polychromatic erythrocyte (PCE) into the red staining normochromatic erythrocyte (NCE) takes approximately 24 h (Schmid, 1976). Thus, sampling of bone marrow cells at about 24 h following treatment allows enough time for the erythroblasts to undergo at least one post-treatment mitosis, to expel their main nucleus, and to mature into erythrocytes. However, if the treatment causes any mitotic delays, a longer interval between treatment and sampling time may be necessary to allow the treated cell population to recover from the cell cycle delay. - Statistics:
- The raw data on the counts of MN-PCE for each animal were first transformed by adding 1 to each count and then taking natural log of the adjusted number. The transformed MNPCE data and the data on percent PCE were analyzed by a three-way analysis of variance (sex, dose, and time), assuming the three-way interaction to be zero. From this initial analysis, the two-way interactions were reviewed for significance. Depending upon this review, the data were analyzed by either one, two, or three-way analysis of variance looking only at main effects. Pairwise comparisons of treated vs. negative control groups were done, if necessary, by a t-test using Bonferroni correction for multiple comparisons. The alpha level at which all the tests were conducted was 0.01.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- There were no significant differences in MN-PCE frequencies between the groups treated with the test material and the negative controls. The ratios of PCE to NCE (expressed as % PCE) observed in the groups treated with the test material were not significantly different from those of the negative control mice.
The positive control chemical, CP, induced a significant increase in the frequencies of micronucleated polychromatic erythrocytes in the bone marrows of both males and females
Any other information on results incl. tables
Table 1 SUMMARY OF THE DATA ON THE FREQUENCIES OF MICRONUCLEATED POLYCHROMATIC ERYTHROCYTES (MN-PCE) IN THE BONE MARROW OF MICE TREATED WITH THE TEST MATERIAL OR CYCLOPHOSPHAMIDE (CP)
24 h sacrifice | 48 h sacrifice | 72 h sacrifice | ||||
Treatment | MN-PCE | % PCE | MN-PCE | % PCE | MN-PCE | % PCE |
Males | ||||||
Water (neg. control) | 0.4 + 0.5 | 63.6 + 6.4 | 0.6 + 0.5 | 67.8 + 4.2 | 0.6 + 0.9 | 64.0 + 7.1 |
DETA 85 mg/kg | 0.0 + 0.0 | 65.7 + 7.0 | 1.0 + 1.0 | 62.0 + 7.2 | 0.8 + 0.4 | 66.4 + 6.1 |
DETA 283 mg/kg | 0.8 + 0.8 | 65.7 + 7.2 | 0.4 + 0.5 | 62.6 + 8.8 | 0.6 + 0.9 | 66.5 + 8.3 |
DETA 850 mg/kg | 0.8 + 1.3 | 62.9 + 3.5 | 0.2 + 0.4 | 62.1 + 7.3 | 0.6 + 0.9 | 69.2 + 4.7 |
CP 120 mg/kg (pos control) | 44.8 + 15.2* | 45.3 + 6.6* | ND | ND | ND | ND |
Females | ||||||
Water (neg control) | 0.2 + 0.4 | 61.6 + 8.9 | 0.4 + 0.5 | 61.8 + 5.3 | 0.4 + 0.9 | 63.9 + 10.7 |
DETA 85 mg/kg | 1.0 + 1.0 | 58.4 + 14.3 | 0.2 + 0.4 | 69.7 + 6.6 | 0.8 + 1.3 | 64.7 + 2.9 |
DETA 283 mg/kg | 1.0 + 0.7 | 56.4 + 9.9 | 0.8 + 0.8 | 64.5 + 9.9 | 2.2 + 1.8 | 69.9 + 4.2 |
DETA 850 mg/kg | 1.2 + 1.3 | 62.5 + 5.4 | 0.2 + 0.4 | 71.1 + 8.8 | 0.8 + 1.1 | 70.6 + 5.9 |
CP 120 mg/kg (pos control) | 56.0 + 17.9* | 47.0 + 10.3 | ND | ND | ND | ND |
5 male and 5 female mice were examined at each dose level; 1000 PCE were examined from each animal.
Data expressed as means and standard deviations.
* Significantly different (alpha < 0.01) from negative control
ND No data
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The test did not significantly increase the frequency of micronucleated polychromatic erythrocytes and was therefore considered negative in the mouse bone marrow micronucleus test. - Executive summary:
Diethylenetriamine (DETA) was evaluated in the mouse bone marrow micronucleus test. The micronucleus test is capable of detecting agents causing chromosomal aberrations and spindle malfunction. The test material was mixed with water and administered to CD-1 (ICR) BR mice by single oral gavage at dose levels of 0 (negative control), 85, 283 and 850 mg/kg body weight (b.w.). Groups of animals were sacrificed at three intervals, viz., 24, 48, and 72 h after treatment. Mice treated with 120 mg/kg b.w. cyclophosphamide and sacrificed at 24 h served as positive controls. There were five animals per sex per dose level per sacrifice time. One thousand polychromatic erythrocytes (PCE) were evaluated from each animal and the frequencies of micronucleated polychromatic erythrocytes (MNPCE) were recorded. There were no significant increases in the frequencies of MN-PCE in groups treated with the test chemical compared to negative controls. The positive control mice showed significant increases in MN-PCE. Hence, under the experimental conditions used, the test chemical was considered negative in the mouse bone marrow micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.